Sign Up
bf/NASDAQ:SLN_icon.jpeg

COM:SILENCE-THERAPEUTICS

Silence Therapeutics

  • Stock

Last Close

540.00

01/01 00:00

Volume Today

913.53K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
asset turnover
0.00
-
0.00
87.38%
0.01
-
0.00
97.89%
0.01
-
0.06
1,103.49%
cash conversion cycle
-30.76
-
-22.19
27.88%
-221.70
-
cash per share
0.48
-
0.43
8.85%
0.81
87.05%
0.56
31.06%
0.62
10.16%
0.38
38.70%
0.45
18.20%
0.46
2.65%
company equity multiplier
1.06
-
1.07
0.94%
1.02
5.04%
1.03
1.10%
1.05
2.04%
1.11
5.57%
2.20
98.66%
9.49
330.65%
days of inventory outstanding
days of payables outstanding
30.76
-
22.19
27.88%
10.62
52.13%
221.70
-
days of sales outstanding
dividend yield
ebit per revenue
-76.94
-
-798.67
938.04%
-13.46
-
-235
1,646.28%
-93.59
-
-6.58
92.97%
ebt per ebit
1
-
1
0%
1
0%
1
0%
1.00
0.40%
1
0.40%
1.00
0.14%
1.00
0.10%
effective tax rate
0.07
-
0.30
296.55%
0.19
37.18%
0.57
208.05%
0.10
81.97%
0.14
39.53%
0.10
32.57%
enterprise value multiple
-19.07
-
-16.48
13.59%
-23.05
39.91%
-24.87
7.88%
-74.19
198.33%
-13.40
81.94%
-13.32
0.55%
-11.05
17.08%
fixed asset turnover
0.54
-
0.03
93.90%
0.56
-
0.01
97.56%
0.40
-
4.86
1,117.39%
free cash flow per share
-0.16
-
-0.19
23.76%
-0.14
26.78%
-0.15
6.81%
-0.14
8.02%
-0.24
72.52%
0.02
109.49%
0.01
53.05%
gross profit margin
-47.27
-
-591.27
1,150.74%
1
-
1
0%
1
-
0.31
68.66%
interest coverage
-250.67
-
-692.03
-
-2.25K
225.36%
inventory turnover
long term debt to capitalization
net income per ebt
1
-
0.93
7.45%
0.70
23.86%
0.81
15.58%
0.43
47.38%
0.90
109.27%
0.86
4.54%
0.90
5.47%
net profit margin
-76.94
-
-739.20
860.75%
-10.96
-
-101.13
822.59%
-80.25
-
-5.94
92.60%
operating cash flow per share
-0.15
-
-0.19
21.93%
-0.13
31.24%
-0.14
11.84%
-0.14
4.83%
-0.24
73.68%
0.02
109.64%
0.02
11.06%
operating cycle
operating profit margin
-76.94
-
-798.67
938.04%
-13.46
-
-235
1,646.28%
-93.59
-
-6.58
92.97%
payables turnover
11.87
-
16.45
38.65%
34.37
108.90%
1.65
-
pretax profit margin
-76.94
-
-798.67
938.04%
-13.46
-
-235.94
1,653.25%
-93.73
-
-6.58
92.98%
price fair value
6.59
-
7.52
14.04%
4.39
41.67%
5.33
21.59%
5.53
3.71%
8.30
50.13%
14.88
79.13%
46.40
211.92%
receivables turnover
return on assets
-0.31
-
-0.37
21.22%
-0.11
71.01%
-0.15
40.10%
-0.03
80.56%
-0.47
1,509.66%
-0.42
10.24%
-0.38
10.92%
return on capital employed
-0.33
-
-0.43
32.21%
-0.16
63.85%
-0.19
22.56%
-0.07
62.44%
-0.59
715.24%
-0.63
7.08%
-0.60
4.86%
return on equity
-0.33
-
-0.40
22.37%
-0.11
72.47%
-0.16
41.65%
-0.03
80.16%
-0.53
1,599.28%
-0.94
78.32%
-3.59
283.63%
total debt to capitalization
0.01
-
0.04
167.92%

All numbers in (except ratios and percentages)